RPG Life Sciences Limited

NSE: RPGLIFE BSE: 532983 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

2902 103(-4%)

Near 52W High of 3082

Volume

12k as on 23, Jun

Open

2,191

High

2,205

Low

2,161

3,005

VWAP

2,330

52 Week High

3,082

52 Week Low

1,733

Viand Research Rating

Quality Score

25/100

Growth Score

68/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

4,799

No. of Shares

1.65

P/E

49.99

P/B

9.42

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

18.85

ROCE

Profit Growth

Listing Date

10-Jun-08

Promoter Holding

72.95%

FII Holding

0.87%

DII Holding

7.45%

Price Chart

Price Performance

1 Week1%

1 Month1%

3 Months32%

6 Months21%

1 Year21%

YTD21%

Moving Average

5 Day SMA2,300

10 Day SMA2,261

20 Day SMA2,219

30 Day SMA2,245

50 Day SMA2,197

61 Day SMA2,137

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	2,437	2,355	2,394	2,441
Resistance 2	2,394	2,348	2,366	2,396
Resistance 1	2,364	2,341	2,348	2,368
Pivot Point	2,321	2,335	2,321	2,323
Support 1	2,291	2,328	2,293	2,295
Support 2	2,248	2,321	2,275	2,250
Support 3	2,218	2,315	2,248	2,222

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,075	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,367	7284	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,71,221	5059	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,077	8838	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,13,284	1402	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,11,092	1114	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,480	2394	3%	3%	11%	25%	23	57.7	0.29	5355
8	MAXHEALTH	1,05,425	1083	2%	1%	8%	14%	0	57.7	0.32	1442
9	MANKIND	1,05,070	2544	0%	0%	18%	3%	49	57.7	0.39	1938
10	DRREDDY	97,179	1165	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 72.95%	(0.01) 72.95%	(0.01) 72.95%	(0.01) 72.95%	(0.01) 72.95%	(0.11) 72.95%	(0.01) 72.82%	(0.01) 72.82%	(0.01) 72.82%	(0.01) 72.82%	(0.01) 72.82%	(0.01) 72.82%	(0.21) 72.82%	(0.01) 72.62%	(0.21) 72.62%	(0.31) 72.41%	(0.01) 72.07%	(0.01) 72.07%	(0.01) 72.07%
FIIs	(-0.11) 0.87%	(-0.11) 1.00%	(-0.21) 1.11%	(-0.11) 1.35%	(0.21) 1.46%	(-0.11) 1.30%	(0.21) 1.35%	(0.31) 1.15%	(0.31) 0.90%	(0.11) 0.56%	(0.11) 0.46%	(-0.11) 0.33%	(0.11) 0.38%	(0.21) 0.25%	(-0.11) 0.08%	(0.01) 0.15%	(-0.11) 0.12%	(0.21) 0.20%	(0.01) 0.02%
DIIs	(0.41) 7.45%	(0.31) 7.04%	(0.21) 6.70%	(0.41) 6.49%	(0.11) 6.14%	(0.61) 6.06%	(2.81) 5.45%	(0.51) 2.61%	(0.41) 2.16%	(0.21) 1.77%	(1.31) 1.57%	(0.21) 0.27%	(0.11) 0.11%	(0.01) 0.01%	(0.01) 0.03%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%
Public	18.72%	19.01%	19.23%	19.22%	19.46%	19.70%	20.40%	23.44%	24.12%	24.85%	25.15%	26.58%	26.70%	27.11%	27.27%	27.43%	27.80%	27.72%	27.90%
No. of Shareholders	25,282	25,905	26,657	25,832	24,867	24,891	23,481	22,232	22,137	21,866	21,088	20,226	20,837	21,360	20,757	22,115	22,821	22,768	23,674

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	177	180	182	169	143	173	172	165	127	154	154	148	118	131	135	129	104	116	112.65	108
Sales Growth % (YoY)	23.6%	4.2%	-	2.1%	-	-	12.1%	11.9%	7.2%	17.7%	13.9%	14.6%	14.2%	13%	19.6%	19.2%	11.9%	7.4%	16%	18%
Sales Growth % (QoQ)	-1.7%	-1.1%	7.7%	18.2%	-17.3%	0.6%	4.2%	29.9%	-17.5%	-	4.1%	25.4%	-9.9%	-3%	4.7%	24%	-10.3%	3%	4.3%	-
Expenses	144	140	143	133	118	124	126	126	106	116	116	116	103	101	105	101	90	91	86.85	85
Operating Profit	33	40	39	35	25	49	46	39	21	38	37	32	16	29	30	28	14	24	25.8	23
OPM %	19	22	21	21	18	28	27	24	16	25	24	22	13	22	22	22	13	21	22.9	21
Other Income	14	-5	16	5	115	3	-25	2	2	2	2	2	2	1	1	1	1	1	0.71	0
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.17	0
Depreciation	6	5	5	5	5	5	5	5	4	4	4	4	4	4	4	4	4	4	3.99	4
Profit before tax	40	29	49	35	135	47	15	36	18	36	35	30	14	26	27	25	11	21	22.35	19
Tax %	26	24	25	26	13	26	72	26	25	26	26	26	25	26	26	28	31	29	29.53	30
Net Profit	30	22	37	26	117	35	4	27	13	26	26	22	10	19	20	18	8	15	15.75	14
Net Profit Growth % (QoQ)	36.4%	-40.5%	42.3%	-77.8%	234.3%	775%	-85.2%	107.7%	-50%	-	18.2%	120%	-47.4%	-5%	11.1%	125%	-46.7%	-4.8%	12.5%	-
Net Profit Growth % (YoY)	-74.4%	-37.1%	825%	-3.7%	800%	34.6%	-84.6%	22.7%	30%	36.8%	30%	22.2%	25%	26.7%	27%	28.6%	-	-	-	-
TTM Net Profit	115	202	215	182	183	79	70	92	87	84	77	71	67	65	61	56.75	52.75	44.75	29.75	0
EPS in Rs	18.08	13.38	22.28	15.9	70.95	21.12	2.54	16.18	8.01	16	15.64	13.36	6.26	11.55	12.07	11.01	4.55	8.85	9.52	8.21

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	708	653	582	513	440	389	376	330	344	294	279	242	236	222
Sales Growth %	8.3%	-	13.5%	16.5%	13.1%	3.6%	13.8%	-4%	17.1%	5.1%	15.3%	2.8%	6.3%	15%
Expenses	560	494	453	408	353	318	315	296	306	274	256	228	224	206
Operating Profit	147	160	129	104	87	71	60	34	38	20	23	14	12	16
OPM %	21	24	22	20	20	18	16	10	11	7	8	6	5	7
Other Income	29	95	7	4	3	1	-5	1	1	18	1	1	66	2
Interest	1	1	1	1	1	2	3	5	5	4	2	3	3	7
Depreciation	21	21	17	16	16	16	16	15	14	11	10	11	11	10
Profit before tax	154	233	118	92	73	54	36	15	20	23	12	1	65	1
Tax %	25	21	26	26	30	25	20	28	34	10	0	0	18	-717
Net Profit	115	183	88	68	51	40	29	11	13	21	12	1	53	4
Net Profit Growth %	-37.2%	108%	29.4%	33.3%	27.5%	37.9%	163.6%	-15.4%	-38.1%	75%	1100%	-98.1%	1225%	-
EPS in Rs	69.64	110.79	53	40.9	31.13	24.19	17.54	6.54	8.13	12.7	7.03	0.6	32.29	2.67
Dividend Payout %	34	0	30	29	31	30	23	37	30	22	23	132	6	45

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	56	78	94	91	65	58	50	46	15	7	33	-2	-6	12
Cash from Investing Activity	86	-42	-79	-106	-35	-8	-11	-19	-16	-30	-15	-10	59	-12
Cash from Financing Activity	-21	-27	-20	-17	-14	-10	-39	-26	0	23	-18	12	-54	0
Net Cash Flow	122	9	-5	-32	17	40	0	0	-1	1	0	0	0	0

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	13	13	13	13	13	13	13	13	13	13	13	13	13	13	13	13
Reserves	592	541	517	366	362	294	243	203	163	147	142	134	120	112	113	63
Borrowings	20	0	0	0	0	0	1	2	12	36	54	45	23	33	15	63
Other Liabilities	168	152	127	175	138	112	88	85	78	54	82	55	49	39	56	67
Total Liabilities	793	706	658	554	513	419	345	303	267	251	291	247	205	197	196	206
Fixed Assets	200	179	184	193	114	124	104	113	123	128	131	137	109	105	106	103
CWIP	20	27	4	14	96	25	31	12	10	17	9	2	2	1	1	1
Investments	85	93	127	93	91	58	0	0	0	0	0	0	0	0	0	0
Other Assets	488	407	343	254	212	211	210	178	134	106	152	108	94	92	89	102
Total Assets	793	706	658	554	513	419	345	303	267	251	291	247	205	197	196	206

Delivery

#	Date	2065 49% 3082	Value (Cr)	Q/T 7	Del 43	Del 7
1	22-Jul	3005	10	6	45	5
2	21-Jul	2998	11	6	43	4
3	20-Jul	3017	35	7	42	15
4	17-Jul	2860	5	6	50	2
5	16-Jul	2922	8	6	36	3
6	15-Jul	2978	43	10	27	12
7	14-Jul	2740	6	6	43	2
8	13-Jul	2823	19	7	28	5
9	10-Jul	2857	55	11	26	15
10	9-Jul	2657	22	10	44	10
11	8-Jul	2452	21	8	26	5
12	7-Jul	2440	3	6	39	1
13	6-Jul	2416	2	4	47	1
14	3-Jul	2416	1	5	42	1
15	2-Jul	2394	4	6	48	2
16	1-Jul	2353	4	8	55	2
17	30-Jun	2292	1	7	68	1
18	29-Jun	2278	2	7	61	1
19	25-Jun	2276	1	6	63	1
20	24-Jun	2289	1	4	51	0
21	23-Jun	2308	3	8	38	1
22	22-Jun	2335	1	6	57	1
23	19-Jun	2277	1	6	72	1
24	18-Jun	2278	1	6	59	1
25	17-Jun	2302	1	5	45	1
26	16-Jun	2289	2	5	41	1
27	15-Jun	2298	4	9	60	2
28	12-Jun	2217	5	6	39	2
29	11-Jun	2200	28	9	13	4
30	10-Jun	2108	1	4	59	1
31	9-Jun	2117	1	5	54	0
32	8-Jun	2089	2	7	42	1
33	5-Jun	2162	3	8	60	2
34	4-Jun	2159	2	8	73	2
35	3-Jun	2198	1	6	43	1
36	2-Jun	2193	1	5	53	1
37	1-Jun	2172	1	4	58	0
38	29-May	2225	3	6	56	2
39	27-May	2233	2	8	51	1
40	26-May	2214	1	5	62	1
41	25-May	2254	2	8	66	2
42	22-May	2294	1	6	53	1
43	21-May	2274	1	5	52	0
44	20-May	2300	2	4	40	1
45	19-May	2283	1	5	52	1
46	18-May	2301	2	5	34	1
47	15-May	2292	1	5	49	1
48	14-May	2348	2	5	53	1

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	4,799c	138c	2.80
22-Jul	4,937c	90c	1.79
21-Jul	5,027c	313c	6.65
17-Jul	4,714c	132c	2.72
16-Jul	4,845c	324c	7.17
15-Jul	4,521c	43c	0.95
14-Jul	4,564c	138c	2.93
13-Jul	4,702c	130c	2.84
10-Jul	4,572c	164c	3.71
09-Jul	4,409c	365c	9.02
08-Jul	4,044c	40c	1.00
07-Jul	4,004c	49c	1.20
06-Jul	4,052c	28c	0.69
02-Jul	4,024c	138c	3.54
01-Jul	3,887c	93c	2.44
30-Jun	3,794c	7c	0.17
29-Jun	3,801c	38c	1.01
26-Jun	3,763c	33L	0.01
25-Jun	3,763c	30c	0.80
24-Jun	3,793c	14c	0.36
23-Jun	3,780c	82c	2.13
22-Jun	3,862c	27c	0.70
19-Jun	3,835c	74c	1.97
18-Jun	3,761c	49c	1.27
17-Jun	3,810c	44c	1.16
16-Jun	3,766c	17c	0.44
15-Jun	3,783c	94c	2.55
12-Jun	3,689c	75c	2.00
11-Jun	3,764c	261c	7.45
10-Jun	3,503c	0	0

Stock Checklist

Price is above from 52 week high low average: 73%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 6 fund scheme(s) across 3 fund house(s) as of Jul26 · Total value ₹3 Cr · 0 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Unifi Mutual Fund	2	0.80%	-	3
Bandhan Mutual Fund	2	0.07%	-	0
Motilal Oswal Mutual Fund	2	0.00%	-	0

RPG Life Sciences Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements